Kazia Therapeutics (KZIA) Retained Earnings (2009 - 2025)
Kazia Therapeutics (KZIA) posted Retained Earnings of -$95.6 million for Q4 2025, down 10.72% on a QoQ basis from -$86.3 million in Q2 2025, and down 16.87% year-over-year from -$115.0 million in Q4 2024.
Kazia Therapeutics (KZIA) Retained Earnings (2009 - 2025) Analysis & Trends
Kazia Therapeutics' Retained Earnings history runs 17 years deep, the most recent figure standing at -$95.6 million for Q4 2025.
- Quarterly Retained Earnings fell 16.87% year-over-year to -$95.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$95.6 million (down 16.87% YoY) and the FY2025 annual result came in at -$86.3 million, down 13.81% from the prior year.
- Retained Earnings was -$95.6 million for Q4 2025 at Kazia Therapeutics, down from -$86.3 million in the prior quarter.
- Across five years, Retained Earnings topped out at $2.5 million in Q2 2023 and bottomed at -$95.6 million in Q4 2025.
- A 5-year average of -$49.3 million and a median of -$58.9 million in 2023 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2021 — Retained Earnings soared 104.22% — and 2024, when it sank 3183.99%.
- Kazia Therapeutics' Retained Earnings stood at -$41.3 million in 2021, then plunged by 30.91% to -$54.0 million in 2022, then decreased by 18.01% to -$63.7 million in 2023, then retreated by 28.35% to -$81.8 million in 2024, then decreased by 16.87% to -$95.6 million in 2025.
- Business Quant data shows KZIA's Retained Earnings at -$95.6 million in Q4 2025, -$86.3 million in Q2 2025, and -$81.8 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Kazia Therapeutics | 4.11 Mn | 4.11 Mn | - | -95.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -95.60 Mn |
| Jun 30, 2025 | -86.35 Mn |
| Dec 31, 2024 | -81.80 Mn |
| Jun 30, 2024 | -75.87 Mn |
| Dec 31, 2023 | -63.74 Mn |
| Jun 30, 2023 | 2.46 Mn |
| Dec 31, 2022 | -54.01 Mn |
| Jun 30, 2022 | 1.73 Mn |
| Dec 31, 2021 | -41.25 Mn |
| Jun 30, 2021 | 1.00 Mn |
| Dec 31, 2020 | -30.86 Mn |
| Jun 30, 2020 | -23.72 Mn |
| Dec 31, 2019 | -21.06 Mn |
| Jun 30, 2019 | 1.43 Mn |
| Dec 31, 2018 | -14.85 Mn |
| Jun 30, 2018 | 1.40 Mn |
| Jun 30, 2017 | 1.45 Mn |
| Dec 31, 2016 | -6.24 Mn |
| Jun 30, 2016 | -127.66 Mn |
| Dec 31, 2015 | -106.83 Mn |